FDA.reportPublic FDA data

aspirin 325 MG / meprobamate 200 MG Oral Tablet [Equagesic]

RxCUI
209823
RxNorm name
aspirin 325 MG / meprobamate 200 MG Oral Tablet [Equagesic]
Term type
SBD
Status
Obsolete
Updated
2026-11-12 18:38:56

RxNorm Status History#

Status
Obsolete
Source
RXNORM
Current
NO
Release start
042005
Active start
042005
Active end
092026
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
aspirin325 MG / 1 EACHaspirinaspirin
meprobamate200 MG / 1 EACHmeprobamatemeprobamate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
aspirin1191
meprobamate6760

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 5 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00008009102rxnav_historical
10551009110rxnav_historical
46672081610rxnav_historical
54569375100rxnav_historical
64248009110rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
941e1ec2-1f14-4153-a5ea-cf7669d5efd1aspirin 325 MG / meprobamate 200 MG Oral Tablet [Equagesic] [SBD] · ASA 325 MG / Meprobamate 200 MG Oral Tablet [Equagesic] [SY] · Equagesic (ASA 325 MG / meprobamate 200 MG) Oral Tablet [SY]31EQUAGESIC ® (meprobamate and aspirin tablets) CIV20080115

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
576d1bf5-9c50-44f8-b910-e446ce3d375aNational Council for Prescription Drug Programs20130213
941E1EC2-1F14-4153-A5EA-CF7669D5EFD1EQUAGESIC ® (meprobamate and aspirin tablets) CIVMikart, Inc.20080115

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN05BCCarbamatesATC1-4meprobamate
ATCA01ADOther agents for local oral treatmentATC1-4aspirin
ATCB01ACPlatelet aggregation inhibitors excl. heparinATC1-4aspirin
ATCN02BASalicylic acid and derivativesATC1-4aspirin
FDASPLN0000175722Nonsteroidal Anti-inflammatory DrugEPChas_epcaspirin
FDASPLN0000175578Platelet Aggregation InhibitorEPChas_epcaspirin
MEDRTD001241AspirinCHEMhas_ingredientaspirin
MEDRTD008620MeprobamateCHEMhas_ingredientmeprobamate
MEDRTD001008Anxiety DisordersDISEASEmay_treatmeprobamate
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treataspirin
MEDRTD001778Blood Coagulation DisordersDISEASEci_withaspirin
MEDRTD001791Blood Platelet DisordersDISEASEci_withaspirin
MEDRTD002544Cerebral InfarctionDISEASEmay_preventaspirin
MEDRTD002644ChickenpoxDISEASEci_withaspirin
MEDRTD002675Child, PreschoolDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withmeprobamate
MEDRTD004342Drug HypersensitivityDISEASEci_withaspirin
MEDRTD005334FeverDISEASEmay_treataspirin
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withmeprobamate
MEDRTD006073GoutDISEASEmay_treataspirin
MEDRTD006261HeadacheDISEASEmay_treatmeprobamate
MEDRTD006396HematemesisDISEASEci_withaspirin
MEDRTD006474Hemorrhagic DisordersDISEASEci_withaspirin
MEDRTD007223InfantDISEASEci_withaspirin
MEDRTD007249InflammationDISEASEmay_treataspirin
MEDRTD010148Intractable PainDISEASEci_withmeprobamate
MEDRTD002546Ischemic Attack, TransientDISEASEmay_preventaspirin
MEDRTD008551MelenaDISEASEci_withaspirin
MEDRTD009127Muscle RigidityDISEASEmay_treatmeprobamate
MEDRTD009128Muscle SpasticityDISEASEmay_treatmeprobamate
MEDRTD009203Myocardial InfarctionDISEASEmay_preventaspirin
MEDRTD009298Nasal PolypsDISEASEci_withaspirin
MEDRTD010003OsteoarthritisDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_preventaspirin
MEDRTD010146PainDISEASEmay_treataspirin
MEDRTD011164PorphyriasDISEASEci_withmeprobamate
MEDRTD011225Pre-EclampsiaDISEASEmay_preventaspirin
MEDRTD011247PregnancyDISEASEci_withmeprobamate
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withaspirin
MEDRTD012213Rheumatic FeverDISEASEmay_treataspirin
MEDRTD013035SpasmDISEASEmay_treatmeprobamate
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moaaspirin
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moameprobamate
MEDRTN0000008486Decreased Central Nervous System Disorganized Electrical ActivityPEci_pemeprobamate
MEDRTN0000008831Decreased Platelet Activating Factor ProductionPEhas_peaspirin
MEDRTN0000008832Decreased Platelet AggregationPEhas_peaspirin
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peaspirin
MEDRTN0000008945Decreased Spinal Cord Organized Electrical ActivityPEhas_pemeprobamate
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_peaspirin
MEDRTN0000000026Hepatic MetabolismPKhas_pkaspirin
MEDRTN0000000042Renal ExcretionPKhas_pkaspirin